Top compounds associated with response to UBD


Feature Type Standardized
Nominal ANOVA
mRNA valdecoxib CTRPv2 pan-cancer AAC -0.029 0.4
mRNA Tamoxifen CTRPv2 pan-cancer AAC 0.03 0.4
mRNA parbendazole CTRPv2 pan-cancer AAC -0.024 0.4
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.029 0.4
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA leptomycin B CTRPv2 pan-cancer AAC -0.026 0.4
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.028 0.4
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC -0.029 0.4
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.4
mRNA pandacostat CTRPv2 pan-cancer AAC 0.029 0.4
Download CSV